Thomas A. McCourt
2014
In 2014, Thomas A. McCourt earned a total compensation of $1M as Senior Vice President, Marketing and Sales and Chief Commercial Officer at Ironwood Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $133,758 |
|---|---|
| Option Awards | $527,928 |
| Salary | $377,600 |
| Other | $7,421 |
| Total | $1,046,707 |
McCourt received $527.9K in option awards, accounting for 50% of the total pay in 2014.
McCourt also received $133.8K in non-equity incentive plan, $377.6K in salary and $7.4K in other compensation.
Rankings
In 2014, Thomas A. McCourt's compensation ranked 7,394th out of 13,032 executives tracked by ExecPay. In other words, McCourt earned more than 43.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,394 out of 13,032 | 43rd |
Division Manufacturing | 2,728 out of 4,966 | 45th |
Major group Chemicals And Allied Products | 926 out of 1,686 | 45th |
Industry group Drugs | 730 out of 1,365 | 47th |
Industry Pharmaceutical Preparations | 564 out of 1,043 | 46th |
Source: SEC filing on April 15, 2016.
McCourt's colleagues
We found five more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2014.
2014
Michael Higgins
Ironwood Pharmaceuticals
Chief Financial Officer
2014
Tom Graney
Ironwood Pharmaceuticals
Chief Financial Officer
2014
Peter Hecht
Ironwood Pharmaceuticals
Chief Executive Officer
2014
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2014
Halley Gilbert
Ironwood Pharmaceuticals
Chief Legal Officer
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019